Most Recent
Two of the world's largest manufacturers of explosives have taken their fight over three patents for a detonation device to the Federal Court.
An anti-lockdown protestor's application to have the High Court hear a challenge to the dismissal of her lawsuit over Victoria's stay-at-home orders has been rejected, with the justices saying the case should be heard by the state's Court of Appeal.
The founder of wholesale food company Hudson Pacific has sued PricewaterhouseCoopers for allegedly providing bad advice on the terms of the $88 million sale of his business to Retail Food Group in 2016.
Virgin Australia has been hit with a shareholder class action over representations made in a 2019 prospectus for a capital raising to fund its $700 million acquisition of the Velocity loyalty program, just six months before the airline sank into administration.
One Nation chief-of-staff James Ashby has failed to revive his lawsuit alleging the federal government breached the Fair Work Act by not paying his $4.5 million legal bill stemming from a dropped sexual harassment case against former House speaker Peter Slipper.
Former Bellamy's Australia director Jan Cameron has consented to preserving up to $5.1 million in her Australian assets and not moving them offshore while proceedings she launched against the Australian Taxation Office are on foot.
Herbert Smith Freehills has partnered with the University of New South Wales on a practical training course for the firm's Australian graduates that will allow them to start practicing sooner.
The nation's peak body for barristers has lashed out at Prime Minister Scott Morrison for saying he has "never had much truck" with barristers during his political career and "didn't care" if they disagreed with him about the need for a federal anti-corruption commission.
Moray & Agnew is facing a lawsuit by a former client who says the firm breached its duties by making an unauthorised $3.3 million transfer while representing him on an investment in a Melbourne storage facility development.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.